Free Trial
→ My top 3 AI picks for the next decade (From The Oxford Club) (Ad)tc pixel
NASDAQ:TRVN

Trevena Earnings Date & Estimates

Trevena logo
$0.07 0.00 (0.00%)
As of 10/12/2026 02:57 PM Eastern

Trevena is estimated to report earnings on Thursday, November 5, 2026.

Research:Profile

Upcoming Earnings Announcement

Announcement Date
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Trevena

Trevena is expected to post earnings of -$50.00 per share on revenue of $0.78 million. Trevena has beaten the consensus EPS estimate in 5 of its last 7 quarters.

Consensus Estimates

Consensus EPS
-$50.00
Expected Revenue
$0.78 million

Recent Track Record

Last Reported
Q3 2024
Last Quarter EPS
-$5.79
Last Quarter Revenue
$0.28 million
EPS Beat Rate
5 of last 7 quarters

Prepare for the Earnings Call

Trevena Earnings FAQ

Trevena (NASDAQ:TRVN) is estimated to report earnings on Thursday, November 5, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Trevena to post earnings of -$50.00 per share for the quarter.

The consensus revenue estimate for Trevena is $0.78 million for the quarter.

Trevena Earnings Headlines

Trevena (NASDAQ:TRVN) Share Price Crosses Above Fifty Day Moving Average - Should You Sell?
October 6, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31090708
Trevena Inc.
May 27, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/TRVN/financials
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
October 13 at 1:00 AM  |  Banyan Hill Publishing (Ad)
Trevena Restructures China Royalty Rights to Exit Debt
January 14, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/trevena-restructures-china-royalty-rights-to-exit-debt?utm_source=marketbeat.com&utm_medium=referral
Softball: Conrad Weiser’s Alex Trevena earns statewide player of the year award; 5 other Berks players honored
July 8, 2025  |  msn.comhttps://www.msn.com/en-us/sports/mlb/softball-conrad-weiser-s-alex-trevena-earns-statewide-player-of-the-year-award-5-other-berks-players-honored/ar-AA1IcIZz
Trevena, Inc. (TRVN) - Yahoo Finance
June 29, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/quote/TRVN/press-releases/
See More Trevena Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Trevena? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Trevena and other key companies, straight to your email.

About Trevena

Trevena (NASDAQ:TRVN) is a biopharmaceutical company focused on developing medicines for central nervous system disorders, with an emphasis on addressing the limitations of existing opioid and other neurological therapies. The company was founded in 2007 and is headquartered in Chesterbrook, Pennsylvania.

Trevena’s principal commercial product is OLINVYK (oliceridine) injection, an intravenous opioid approved by the U.S. Food and Drug Administration for the management of acute pain in adults severe enough to require an intravenous opioid analgesic. OLINVYK was designed to provide pain relief while potentially reducing certain adverse effects associated with conventional opioids, although it carries the risks and precautions associated with opioid medicines.

The company has also researched additional compounds for neurological conditions, including investigational therapies intended for disorders such as pain and epilepsy. Trevena’s commercial activities have primarily focused on the United States, while its development and licensing efforts have included relationships intended to support access to international markets. Information about the company’s current leadership and operating status may change over time.

View Trevena Profile
Earnings Tools